BioCentury
ARTICLE | Financial News

Akebia raises $89.3M in follow-on

March 30, 2018 5:58 PM UTC

Kidney disease company Akebia Therapeutics Inc. (NASDAQ:AKBA) raised $89.3 million on March 23 through the sale of 8.5 million shares at $10.50 in a follow-on underwritten by Morgan Stanley. The price is a 10% discount to Akebia's close of $11.68 on March 22, when the company proposed after market hours to raise $85 million...